Philipp Maximilian Kazmierczak
Overview
Explore the profile of Philipp Maximilian Kazmierczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
36
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodler S, Danninger D, Eismann L, Kazmierczak P, Jokisch F, Li M, et al.
World J Urol
. 2024 Apr;
42(1):242.
PMID: 38635030
Background: Salvage radical prostatectomy (sRP) is an important treatment option for patients with recurrent prostate cancer (PCa) after radiotherapy (RT) or focal therapy (FT). However, health-related quality of life (HRQOL)...
2.
Salvermoser L, Goldberg S, Alunni-Fabbroni M, Kazmierczak P, Groper M, Schafer J, et al.
Transl Oncol
. 2024 Feb;
43:101919.
PMID: 38401507
Background And Purpose: To determine the potential prognostic value of proliferation and angiogenesis plasma proteins following CT-guided high dose rate brachytherapy (HDR-BT) of hepatocellular carcinoma (HCC). Materials And Methods: For...
3.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, et al.
Radiat Oncol
. 2023 Jul;
18(1):125.
PMID: 37507808
Background And Aims: Prognostic biomarkers identifying patients with early tumor progression after local ablative therapy remain an unmet clinical need. The aim of this study was to investigate circulating miR-21...
4.
Schmidt V, Dietrich O, Kazmierczak P, Seidensticker M, Ricke J, Armbruster M
Diagn Interv Radiol
. 2023 Mar;
29(1):128-137.
PMID: 36960560
Purpose: This study aimed to determine the optimal sequence parameters of a real-time T1-weighted (T1w) gradient echo (GRE) sequence for magnetic resonance (MR)-guided liver interventions. Methods: We included 94 patients...
5.
Vera J, Lai X, Baur A, Erdmann M, Gupta S, Gutta C, et al.
Brief Bioinform
. 2022 Oct;
23(6).
PMID: 36252807
We live in an unprecedented time in oncology. We have accumulated samples and cases in cohorts larger and more complex than ever before. New technologies are available for quantifying solid...
6.
Weinhold P, Jokisch F, Schulz G, Buchner A, Kazmierczak P, Kretschmer A, et al.
Urol Int
. 2022 Feb;
106(8):806-815.
PMID: 35114679
Introduction: Palliative radical cystectomy (pRC) may be offered to selected bladder cancer (BC) patients with grievous local symptoms. However, there is only scarce information on perioperative complications and prognosis, especially...
7.
Schmidt V, Arnone F, Dietrich O, Seidensticker M, Armbruster M, Ricke J, et al.
Sci Rep
. 2021 Nov;
11(1):22963.
PMID: 34824361
Needle artifacts pose a major limitation for MRI-guided interventions, as they impact the visually perceived needle size and needle-to-target-distance. The objective of this agar liver phantom study was to establish...
8.
Eschbach R, Clevert D, Hirner-Eppeneder H, Ingrisch M, Moser M, Schuster J, et al.
PLoS One
. 2017 Jan;
12(1):e0169323.
PMID: 28060884
Objectives: To investigate contrast-enhanced ultrasound (CEUS) with VEGFR2-targeted microbubbles for monitoring therapy effects of regorafenib on experimental colon carcinomas in rats with correlation to dynamic contrast-enhanced MRI (DCE-MRI) and immunohistochemistry....
9.
Kazmierczak P, Schneider M, Habereder T, Hirner-Eppeneder H, Eschbach R, Moser M, et al.
Invest Radiol
. 2016 Apr;
51(11):746-755.
PMID: 27082316
Objectives: The aim of this study was to investigate magnetic resonance imaging (MRI) with αvß3-integrin-targeted ultrasmall superparamagnetic iron oxide nanoparticles (RGD-USPIO) for the in vivo monitoring of early antiangiogenic therapy...